Detection of RSK3 in gliomas by western blot required very long exposure times (Fig. S2C) and is consistent with the apparent lack of RSK3 expression in GBM cell lines (Roffé et al., 2015). The gene discussed is RPS6KA2; the disease is central nervous system cancer.